×
About 9,420 results

ALLMedicine Myasthenia Gravis Center

Research & Reviews  4,485 results

What's in the Neuromuscular Junction Literature?
https://doi.org/10.1097/CND.0000000000000285
Journal of Clinical Neuromuscular Disease; Lacomis D

May 26th, 2020 - Four retrospective studies from the United States, Europe, and Asia address outcomes in juvenile myasthenia gravis. Common features include earlier onset with ocular myasthenia gravis (MG) and generally good outcomes overall. Patients who were ser...

A Telephonic Single Breath Count Test For Screening Of Exacerbations Of Myasthenia Grav...
https://doi.org/10.1002/mus.26987
Muscle & Nerve; Kukulka K, Gummi RR et. al.

May 24th, 2020 - Patients with myasthenia gravis (MG) may experience worsening symptoms outside of a clinical setting. A method of diagnosing and triaging such individuals would be valuable. This study gauged the viability of a nurse-administered single breath cou...

Investigation of GHSR methylation levels in thymomas from patients with Myasthenia Gravis.
https://doi.org/10.1016/j.gene.2020.144774
Gene Coppedè F, Stoccoro A et. al.

May 22nd, 2020 - Hypermethylation of the growth hormone secretagogue receptor gene (GHSR) is increasingly observed in human cancers, suggesting that it could represent a pan-cancer biomarker of clinical interest. However, little is still known concerning GHSR meth...

Neuromyelitis optica in patients with myasthenia gravis: Two case-reports.
https://doi.org/10.1016/j.msard.2020.102173
Multiple Sclerosis and Related Disorders; Castro-Suarez S, Guevara-Silva E et. al.

May 22nd, 2020 - Neuromyelitis optica spectrum disorders (NMOSD) and myasthenia gravis (MG) are disorders that affect the central nervous system and the neuromuscular junction respectively. Although both conditions are rare, reports of the coexistence of these two...

Quantitative features and clinical significance of two subpopulations of AChR-specific ...
https://doi.org/10.1016/j.clim.2020.108462
Clinical Immunology (Orlando, Fla.); Liu X, Ma Q et. al.

May 21st, 2020 - Acetylcholine receptor (AChR)-specific CD4+ T cells play a driving role in myasthenia gravis (MG) by regulating the production of autoantibodies. However, the quantitative features of AChR-specific T cells and their clinical significance in MG are...

see more →

Guidelines  9 results

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic synd...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105910
Journal of the Neurological Sciences; , Jacob S et. al.

Apr 4th, 2020 - Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.|2020| ,Jacob S,Muppidi S,Guidon A,Guptill J,|complications,drug therapy,epidemiology,therapeutic use,therapeutic use,t...

The Association of British Neurologists' myasthenia gravis guidelines.
https://doi.org/10.1111/nyas.13503
Annals of the New York Academy of Sciences; Sussman J, Farrugia ME et. al.

Nov 9th, 2017 - Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction for which many therapies were developed before the era of evidence-based medicine. Despite the basic principles of treatment being well known, patients continue to recei...

International consensus guidance for management of myasthenia gravis: Executive summary.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977114
Neurology Sanders DB, Wolfe GI et. al.

Jun 30th, 2016 - To develop formal consensus-based guidance for the management of myasthenia gravis (MG). In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international expe...

Guidelines for treatment of autoimmune neuromuscular transmission disorders.
https://doi.org/10.1111/j.1468-1331.2010.03019.x
European Journal of Neurology; Skeie GO, Apostolski S et. al.

Apr 20th, 2010 - Important progress has been made in our understanding of the autoimmune neuromuscular transmission (NMT) disorders; myasthenia gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS) and neuromyotonia (Isaacs' syndrome). To prepare consensus guideli...

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological ...
https://doi.org/10.1111/j.1468-1331.2008.02246.x
European Journal of Neurology; Elovaara I, Apostolski S et. al.

Sep 17th, 2008 - Despite high-dose intravenous immunoglobulin (IVIG) is widely used in treatment of a number of immune-mediated neurological diseases, the consensus on its optimal use is insufficient. To define the evidence-based optimal use of IVIG in neurology, ...

see more →

Drugs  57 results see all →

Clinicaltrials.gov  4,673 results

What's in the Neuromuscular Junction Literature?
https://doi.org/10.1097/CND.0000000000000285
Journal of Clinical Neuromuscular Disease; Lacomis D

May 26th, 2020 - Four retrospective studies from the United States, Europe, and Asia address outcomes in juvenile myasthenia gravis. Common features include earlier onset with ocular myasthenia gravis (MG) and generally good outcomes overall. Patients who were ser...

A Telephonic Single Breath Count Test For Screening Of Exacerbations Of Myasthenia Grav...
https://doi.org/10.1002/mus.26987
Muscle & Nerve; Kukulka K, Gummi RR et. al.

May 24th, 2020 - Patients with myasthenia gravis (MG) may experience worsening symptoms outside of a clinical setting. A method of diagnosing and triaging such individuals would be valuable. This study gauged the viability of a nurse-administered single breath cou...

Investigation of GHSR methylation levels in thymomas from patients with Myasthenia Gravis.
https://doi.org/10.1016/j.gene.2020.144774
Gene Coppedè F, Stoccoro A et. al.

May 22nd, 2020 - Hypermethylation of the growth hormone secretagogue receptor gene (GHSR) is increasingly observed in human cancers, suggesting that it could represent a pan-cancer biomarker of clinical interest. However, little is still known concerning GHSR meth...

Neuromyelitis optica in patients with myasthenia gravis: Two case-reports.
https://doi.org/10.1016/j.msard.2020.102173
Multiple Sclerosis and Related Disorders; Castro-Suarez S, Guevara-Silva E et. al.

May 22nd, 2020 - Neuromyelitis optica spectrum disorders (NMOSD) and myasthenia gravis (MG) are disorders that affect the central nervous system and the neuromuscular junction respectively. Although both conditions are rare, reports of the coexistence of these two...

Quantitative features and clinical significance of two subpopulations of AChR-specific ...
https://doi.org/10.1016/j.clim.2020.108462
Clinical Immunology (Orlando, Fla.); Liu X, Ma Q et. al.

May 21st, 2020 - Acetylcholine receptor (AChR)-specific CD4+ T cells play a driving role in myasthenia gravis (MG) by regulating the production of autoantibodies. However, the quantitative features of AChR-specific T cells and their clinical significance in MG are...

see more →

News  177 results

Rituximab Promising in New-Onset Myasthenia Gravis
https://www.medscape.com/viewarticle/930271

May 10th, 2020 - Patients with myasthenia gravis (MG) who are treated early with the monoclonal antibody rituximab (multiple brands) achieve remission sooner than those treated later in the disease process, new research suggests. Investigators compared patients wi...

Zilucoplan improved efficacy outcomes in myasthenia gravis
https://www.mdedge.com/jcomjournal/article/217505/rare-diseases/zilucoplan-improved-efficacy-outcomes-myasthenia-gravis?channel=39313
Andrew D. Bowser

Feb 19th, 2020 - The complement C5 inhibitor zilucoplan significantly improved muscle weakness and daily functioning in patients with moderate to severe generalized myasthenia gravis (gMG), according to investigators who conducted a phase 2, randomized, placebo-co.

AChR autoantibody subtype testing may improve accuracy of myasthenia gravis evaluations
https://www.mdedge.com/neurology/article/211179/neuromuscular-disorders/achr-autoantibody-subtype-testing-may-improve?channel=53
Jake Remaly

Oct 29th, 2019 - AUSTIN, TEX. – When testing for acetylcholine receptor (AChR) autoantibodies in patients with suspected myasthenia gravis, testing for binding antibodies and for modulating antibodies is more accurate than testing for either subtype alone, researc.

Which patients are most likely to have a positive RNS test for myasthenia gravis?
https://www.mdedge.com/jcomjournal/article/210392/neuromuscular-disorders/which-patients-are-most-likely-have-positive-rns?channel=39313
Erik Greb

Oct 18th, 2019 - AUSTIN, TEX. – Patients with suspected myasthenia gravis are more likely to have positive repetitive nerve stimulation (RNS) findings if they undergo testing in an inpatient setting, are seropositive, or are classified as Myasthenia Gravis Foundat.

Neurologists consider flu shot safe in most patients with autoimmune neuromuscular disorders
https://www.mdedge.com/jcomjournal/article/210352/neuromuscular-disorders/neurologists-consider-flu-shot-safe-most-patients?channel=39313
Erik Greb

Oct 17th, 2019 - AUSTIN, TEX. – Neurologists consider influenza vaccination to be safe in most patients with autoimmune neuromuscular disorders such as myasthenia gravis and chronic inflammatory demyelinating polyneuropathy (CIDP), according to a survey presented.

see more →

Patient Education  19 results see all →